These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7581156)

  • 21. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical skin graft-vs.-host disease following bone marrow transplantation in an infant.
    Kuskonmaz B; Güçer S; Boztepe G; Cetin M; Uckan D
    Pediatr Transplant; 2007 Mar; 11(2):214-6. PubMed ID: 17300504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological changes of bile duct in experimental graft-versus-host disease across minor histocompatibility barriers. I. Light microscopic and immunocytochemical observations.
    Nonomura A; Koizumi H; Yoshida K; Ohta G
    Acta Pathol Jpn; 1987 May; 37(5):763-73. PubMed ID: 3307287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver diseases in bone marrow transplant patients.
    Picardi M; De Rosa G; Muretto P; Pezzullo L; Raiola A; Rotoli B
    Bone Marrow Transplant; 1998 Sep; 22(6):571-3. PubMed ID: 9758345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
    Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G
    Bone Marrow Transplant; 2003 Nov; 32(9):881-7. PubMed ID: 14561988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.
    Ochs LA; Miller WJ; Filipovich AH; Haake RJ; McGlave PB; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ
    Bone Marrow Transplant; 1994 Apr; 13(4):455-60. PubMed ID: 8019471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
    Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
    Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
    Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
    Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese.
    Morishima Y; Kodera Y; Hirabayashi N; Tanimoto M; Matsuyama T; Horibe K; Ohta H; Mizuno S; Morishita Y; Yamauchi T
    Bone Marrow Transplant; 1995 Feb; 15(2):235-9. PubMed ID: 7773212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected late graft failure 9 months after HLA-identical bone marrow transplant (BMT) for chronic myeloid leukemia (CML): treatment with a second BMT.
    Gil-Fernández JJ; Arranz R; Cámara R; Alegre A; Figuera A; Fernández-Rañada JM
    Haematologica; 1998 Mar; 83(3):285-7. PubMed ID: 9580418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late development of graft-versus-host disease in an autologous BMT recipient.
    Appleton AL; Sviland L; Wilkes J; Pearson AD; Malcolm AJ
    Bone Marrow Transplant; 1994 Jun; 13(6):823-5. PubMed ID: 7920321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors].
    Hamazaki T; Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Sasabe M; Kishimoto T; Inoue A; Kawa K
    Rinsho Ketsueki; 2000 May; 41(5):430-6. PubMed ID: 10879106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal bone marrow transplantation between brother and sister.
    Rana I; Pinto RM; Caniglia M; Lombardi A; De Rossi G
    Bone Marrow Transplant; 2002 Apr; 29(8):705-7. PubMed ID: 12180117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT.
    Kist-van Holthe JE; van Zwet JM; Brand R; van Weel MH; Vossen JM; van der Heijden AJ
    Bone Marrow Transplant; 1998 Sep; 22(6):559-64. PubMed ID: 9758343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
    Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
    Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.